|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Molina JR, Yang P, Cassivi SD, Schild SE
and Adjei AA: Non-small cell lung cancer: Epidemiology, risk
factors, treatment, and survivorship. Mayo Clin Proc. 83:584–594.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lei H, Wang K, Jiang T, Lu J, Dong X, Wang
F, Li Q and Zhao L: KIAA0101 and UbcH10 interact to regulate
non-small cell lung cancer cell proliferation by disrupting the
function of the spindle assembly checkpoint. BMC Cancer.
20:9572020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lv W, Su B, Li Y, Geng C and Chen N:
KIAA0101 inhibition suppresses cell proliferation and cell cycle
progression by promoting the interaction between p53 and Sp1 in
breast cancer. Biochem Biophys Res Commun. 503:600–606. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jain M, Zhang L, Patterson EE and Kebebew
E: KIAA0101 is overexpressed, and promotes growth and invasion in
adrenal cancer. PLoS One. 6:e268662011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tantiwetrueangdet A, Panvichian R,
Sornmayura P, Leelaudomlipi S and Macoska JA: PCNA-associated
factor (KIAA0101/PCLAF) overexpression and gene copy number
alterations in hepatocellular carcinoma tissues. BMC Cancer.
21:2952021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fan S and Li X, Tie L, Pan Y and Li X:
KIAA0101 is associated with human renal cell carcinoma
proliferation and migration induced by erythropoietin. Oncotarget.
7:13520–13537. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kato T, Daigo Y, Aragaki M, Ishikawa K,
Sato M and Kaji M: Overexpression of KIAA0101 predicts poor
prognosis in primary lung cancer patients. Lung Cancer. 75:110–118.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Patop IL, Wüst S and Kadener S: Past,
present, and future of circRNAs. EMBO J. 38:e1008362019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Li P
and Wu M: CircRNA: Functions and properties of a novel potential
biomarker for cancer. Mol Cancer. 16:942017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rybak-Wolf A, Stottmeister C, Glazar P,
Jens M, Pino N, Giusti S, Hanan M, Behm M, Bartok O, Ashwal-Fluss
R, et al: Circular RNAs in the mammalian brain are highly abundant,
conserved, and dynamically expressed. Mol Cell. 58:870–885. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li C, Zhang L, Meng G, Wang Q, Lv X and
Zhang J: Circular RNAs: Pivotal molecular regulators and novel
diagnostic and prognostic biomarkers in non-small cell lung cancer.
J Cancer Res Clin Oncol. 145:2875–2889. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Z, Yao H, Wang S, Li G and Gu X:
CircTADA2A suppresses the progression of colorectal cancer via
miR-374a-3p/KLF14 axis. J Exp Clin Cancer Res. 39:1602020.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu JZ, Shao CC, Wang XJ, Zhao X, Chen JQ,
Ouyang YX, Feng J, Zhang F, Huang WH, Ying Q, et al: circTADA2As
suppress breast cancer progression and metastasis via targeting
miR-203a-3p/SOCS3 axis. Cell Death Dis. 10:1752019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu Y, Xie Z, Chen J, Ni W, Ma Y, Huang K,
Wang G, Wang J, Ma J, Shen S and Fan S: Circular RNA circTADA2A
promotes osteosarcoma progression and metastasis by sponging
miR-203a-3p and regulating CREB3 expression. Mol Cancer. 18:732019.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The Eighth Edition AJCC Cancer Staging Manual:
Continuing to build a bridge from a population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhong S, Wang J, Zhang Q, Xu H and Feng J:
CircPrimer: A software for annotating circRNAs and determining the
specificity of circRNA primers. BMC Bioinformatics. 19:2922018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41:D991–D995. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zeng K, Chen X, Xu M, Liu X, Hu X, Xu T,
Sun H, Pan Y, He B and Wang S: CircHIPK3 promotes colorectal cancer
growth and metastasis by sponging miR-7. Cell Death Dis. 9:4172018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zheng Q, Bao C, Guo W, Li S, Chen J, Chen
B, Luo Y, Lyu D, Li Y, Shi G, et al: Circular RNA profiling reveals
an abundant circHIPK3 that regulates cell growth by sponging
multiple miRNAs. Nat Commun. 7:112152016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Y, Lu Z, Wang N, Feng J, Zhang J,
Luan L, Zhao W and Zeng X: Long noncoding RNA DANCR promotes
colorectal cancer proliferation and metastasis via miR-577
sponging. Exp Mol Med. 50:1–17. 2018. View Article : Google Scholar
|
|
23
|
Wang Y, Yang T, Liu Y, Zhao W, Zhang Z, Lu
M and Zhang W: Decrease of miR-195 promotes chondrocytes
proliferation and maintenance of chondrogenic phenotype via
targeting FGF-18 pathway. Int J Mol Sci. 18:9752017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Y, Zeng X, Wang N, Zhao W, Zhang X,
Teng S, Zhang Y and Lu Z: Long noncoding RNA DANCR, working as a
competitive endogenous RNA, promotes ROCK1-mediated proliferation
and metastasis via decoying of miR-335-5p and miR-1972 in
osteosarcoma. Mol Cancer. 17:892018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cheng Z, Yu C, Cui S, Wang H, Jin H, Wang
C, Li B, Qin M, Yang C, He J, et al: circTP63 functions as a ceRNA
to promote lung squamous cell carcinoma progression by upregulating
FOXM1. Nat Commun. 10:32002019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qu S, Liu Z, Yang X, Zhou J, Yu H, Zhang R
and Li H: The emerging functions and roles of circular RNAs in
cancer. Cancer Lett. 414:301–309. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dudekula DB, Panda AC, Grammatikakis I, De
S, Abdelmohsen K and Gorospe M: CircInteractome: A web tool for
exploring circular RNAs and their interacting proteins and
microRNAs. RNA Biol. 13:34–42. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yu J, Xu QG, Wang ZG, Yang Y, Zhang L, Ma
JZ, Sun SH, Yang F and Zhou WP: Circular RNA cSMARCA5 inhibits
growth and metastasis in hepatocellular carcinoma. J Hepatol.
68:1214–1227. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cai H, Liu X, Zheng J, Xue Y, Ma J, Li Z,
Xi Z, Li Z, Bao M and Liu Y: Long non-coding RNA taurine
upregulated 1 enhances tumor-induced angiogenesis through
inhibiting microRNA-299 in human glioblastoma. Oncogene.
36:318–331. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Song YX, Sun JX, Zhao JH, Yang YC, Shi JX,
Wu ZH, Chen XW, Gao P, Miao ZF and Wang ZN: Non-coding RNAs
participate in the regulatory network of CLDN4 via ceRNA mediated
miRNA evasion. Nat Commun. 8:2892017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nan A, Chen L, Zhang N, Jia Y, Li X, Zhou
H, Ling Y, Wang Z, Yang C, Liu S and Jiang Y: Circular RNA
circNOL10 inhibits lung cancer development by promoting
SCLM1-mediated transcriptional regulation of the humanin
polypeptide family. Adv Sci (Weinh). 6:18006542019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:e050052015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Anastasiadou E, Jacob LS and Slack FJ:
Non-coding RNA networks in cancer. Nat Rev Cancer. 18:5–18. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kristensen LS, Andersen MS, Stagsted LVW,
Ebbesen KK and Hansen TB: The biogenesis, biology and
characterization of circular RNAs. Nat Rev Genet. 20:675–691. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Salzman J: Circular RNA Expression: Its
potential regulation and function. Trends Genet. 32:309–316. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Su M, Xiao Y, Ma J, Tang Y, Tian B, Zhang
Y, Li X, Wu Z, Yang D, Zhou Y, et al: Circular RNAs in Cancer:
Emerging functions in hallmarks, stemness, resistance and roles as
potential biomarkers. Mol Cancer. 18:902019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cui C, Yang J, Li X, Liu D, Fu L and Wang
X: Functions and mechanisms of circular RNAs in cancer radiotherapy
and chemotherapy resistance. Mol Cancer. 19:582020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li X, Yang L and Chen LL: The biogenesis,
functions, and challenges of circular RNAs. Mol Cell. 71:428–442.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang Q, Li F, He AT and Yang BB: Circular
RNAs: Expression, localization, and therapeutic potentials. Mol
Ther. 29:1683–1702. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhong Y, Du Y, Yang X, Mo Y, Fan C, Xiong
F, Ren D, Ye X, Li C, Wang Y, et al: Circular RNAs function as
ceRNAs to regulate and control human cancer progression. Mol
Cancer. 17:792018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cheng J, Chen Y, Zhao P, Li N, Lu J, Li J,
Liu Z, Lv Y and Huang C: Dysregulation of miR-638 in hepatocellular
carcinoma and its clinical significance. Oncol Lett. 13:3859–3865.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li M, Wang J and Liu H: Downregulation of
miR-638 promotes progression of breast cancer and is associated
with prognosis of breast cancer patients. Onco Targets Ther.
11:6871–6877. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Shen Y, Chen H, Gao L, Zhang W, He J, Yang
X, Qin L, Xue X and Guo Z: MiR-638 acts as a tumor suppressor gene
in gastric cancer. Oncotarget. 8:108170–108180. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wei H, Zhang JJ and Tang QL: MiR-638
inhibits cervical cancer metastasis through Wnt/β-catenin signaling
pathway and correlates with prognosis of cervical cancer patients.
Eur Rev Med Pharmacol Sci. 21:5587–5593. 2017.PubMed/NCBI
|
|
45
|
Yan S, Dang G, Zhang X, Jin C, Qin L, Wang
Y, Shi M, Huang H and Duan Q: Downregulation of circulating
exosomal miR-638 predicts poor prognosis in colon cancer patients.
Oncotarget. 8:72220–72226. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zheng DH, Wang X, Lu LN, Chen DL, Chen JM,
Lin FM and Xu XB: MiR-638 serves as a tumor suppressor by targeting
HOXA9 in glioma. Eur Rev Med Pharmacol Sci. 22:7798–7806.
2018.PubMed/NCBI
|
|
47
|
Xia Y, Wu Y, Liu B, Wang P and Chen Y:
Downregulation of miR-638 promotes invasion and proliferation by
regulating SOX2 and induces EMT in NSCLC. FEBS Lett. 588:2238–2245.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yu CY, Li TC, Wu YY, Yeh CH, Chiang W,
Chuang CY and Kuo HC: The circular RNA circBIRC6 participates in
the molecular circuitry controlling human pluripotency. Nat Commun.
8:11492017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chen H, Xia B, Liu T, Lin M and Lou G:
KIAA0101, a target gene of miR-429, enhances migration and
chemoresistance of epithelial ovarian cancer cells. Cancer Cell
Int. 16:742016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jain N, Roy J, Das B and Mallick B:
miR-197-5p inhibits sarcomagenesis and induces cellular senescence
via repression of KIAA0101. Mol Carcinog. 58:1376–1388. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Samantarrai D and Mallick B: miR-429
inhibits metastasis by targeting KIAA0101 in soft tissue sarcoma.
Exp Cell Res. 357:33–39. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The rosetta stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
